These findings suggest that ID2 may modulate MMP9 in thyroid cancer metastasis, as further corroborated by in vivo experiments, thereby providing additional evidence for the facilitation of thyroid cancer proliferation and metastatic potential by ID2. This evidence concerns the gene MMP9 and thyroid gland carcinoma.